These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20335490)

  • 21. Differential influence of the E4 adenoviral genes on viral and cellular promoters.
    Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M
    J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
    Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
    J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique genome arrangement of an ovine adenovirus: identification of new proteins and proteinase cleavage sites.
    Vrati S; Brookes DE; Strike P; Khatri A; Boyle DB; Both GW
    Virology; 1996 Jun; 220(1):186-99. PubMed ID: 8659111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene.
    Toes RE; Offringa R; Blom RJ; Brandt RM; van der Eb AJ; Melief CJ; Kast WM
    J Immunol; 1995 Apr; 154(7):3396-405. PubMed ID: 7534797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes.
    Gallimore PH; Grand RJ; Byrd PJ
    Anticancer Res; 1986; 6(3 Pt B):499-508. PubMed ID: 3017183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes.
    Scaria A; Curiel DT; Kay MA
    Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of early region 4 of porcine adenovirus type 3.
    Li X; Babiuk LA; Tikoo SK
    Virus Res; 2004 Sep; 104(2):181-90. PubMed ID: 15246655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical-viral interactions and multistep aspects of cell transformation.
    Fisher PB; Weinstein IB
    IARC Sci Publ; 1980; (27):113-31. PubMed ID: 7439961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
    Sircar S; Rodrigues M; Weber JM
    Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
    Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
    Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2.
    Glaunsinger BA; Weiss RS; Lee SS; Javier R
    EMBO J; 2001 Oct; 20(20):5578-86. PubMed ID: 11598001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9.
    Thomas DL; Shin S; Jiang BH; Vogel H; Ross MA; Kaplitt M; Shenk TE; Javier RT
    J Virol; 1999 Apr; 73(4):3071-9. PubMed ID: 10074157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.
    Dedieu JF; Vigne E; Torrent C; Jullien C; Mahfouz I; Caillaud JM; Aubailly N; Orsini C; Guillaume JM; Opolon P; Delaere P; Perricaudet M; Yeh P
    J Virol; 1997 Jun; 71(6):4626-37. PubMed ID: 9151856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the transforming activities of adenovirus oncogenes.
    Nevels M; Dobner T
    Methods Mol Med; 2007; 131():187-95. PubMed ID: 17656783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9.
    Thomas DL; Schaack J; Vogel H; Javier R
    J Virol; 2001 Jan; 75(2):557-68. PubMed ID: 11134268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hijacking Dlg1 for oncogenic phosphatidylinositol 3-kinase activation in human epithelial cells is a conserved mechanism of human adenovirus E4-ORF1 proteins.
    Kumar M; Kong K; Javier RT
    J Virol; 2014 Dec; 88(24):14268-77. PubMed ID: 25253337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-generation adenovirus vectors.
    Wang Q; Finer MH
    Nat Med; 1996 Jun; 2(6):714-6. PubMed ID: 8640568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.